| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical and Environmental Epidemiology Branches, National Cancer Institute, Bethesda, Maryland 20892
A search of the Cancer Family Registry of the National Cancer Institute revealed 24 kindreds with the syndrome of sarcoma, breast carcinoma, and other neoplasms in young patients. Cancer developed in an autosomal dominant pattern in 151 blood relatives, 119 (79%) of whom were affected before 45 years of age. These young patients had a total of 50 bone and soft tissue sarcomas of diverse histological subtypes and 28 breast cancers. Additional features of the syndrome included an excess of brain tumors (14 cases), leukemia (9 cases), and adrenocortical carcinoma (4 cases) before age 45 years. These neoplasms also accounted for 73% of the multiple primary cancers occurring in 15 family members. Six of these patients had second cancers linked to radiotherapy. The diversity of tumor types in this syndrome suggests pathogenetic mechanisms which differ from hereditary cancers arising in single organs or tissues. The syndrome is presently diagnosed on clinical grounds; laboratory markers are needed to identify high-risk individuals and families and to provide insights into susceptibility mechanisms that may be shared by a wide variety of cancers.
1 A contract with Capital Systems Group, Inc. (NO1-CP-31024) provided support for the Cancer Family Registry system.
2 To whom requests for reprints should be addressed, at the Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.
Received 1/ 4/88. Revised 5/25/88. Accepted 6/ 3/88.
This article has been cited by other articles:
|
|
 |
|
  D. C. Allain Genetic Counseling and Testing for Common Hereditary Breast Cancer Syndromes: A Paper from the 2007 William Beaumont Hospital Symposium on Molecular Pathology J. Mol. Diagn., September 1, 2008; 10(5): 383 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Bougeard, R Sesboue, S Baert-Desurmont, S Vasseur, C Martin, J Tinat, L Brugieres, A Chompret, B B.-d. Paillerets, D Stoppa-Lyonnet, et al. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families J. Med. Genet., August 1, 2008; 45(8): 535 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Spunt, S. X. Skapek, and C. M. Coffin Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas Oncologist, June 1, 2008; 13(6): 668 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Masciari, A. D. Van den Abbeele, L. R. Diller, I. Rastarhuyeva, J. Yap, K. Schneider, L. Digianni, F. P. Li, J. F. Fraumeni Jr, S. Syngal, et al. F18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome JAMA, March 19, 2008; 299(11): 1315 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D G Evans, J M Birch, and S A Narod Is CHEK2 a cause of the Li Fraumeni syndrome? J. Med. Genet., January 1, 2008; 45(1): 63 - 64. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Monti, Y. Ciribilli, J. Jordan, P. Menichini, D. M. Umbach, M. A. Resnick, L. Luzzatto, A. Inga, and G. Fronza Transcriptional Functionality of Germ Line p53 Mutants Influences Cancer Phenotype Clin. Cancer Res., July 1, 2007; 13(13): 3789 - 3795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Y. Chong, H. Demirci, S. M. Ronan, A. Flint, and V. M. Elner Orbital Rhabdomyosarcoma in Li-Fraumeni Syndrome Arch Ophthalmol, April 1, 2007; 125(4): 566 - 569. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ohmiya, A. Taguchi, N. Mabuchi, A. Itoh, Y. Hirooka, Y. Niwa, and H. Goto MDM2 Promoter Polymorphism Is Associated With Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis J. Clin. Oncol., September 20, 2006; 24(27): 4434 - 4440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R H Scott, C A Stiller, L Walker, and N Rahman Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour J. Med. Genet., September 1, 2006; 43(9): 705 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Wu, S. Shete, C. I. Amos, and L. C. Strong Joint Effects of Germ-Line p53 Mutation and Sex on Cancer Risk in Li-Fraumeni Syndrome Cancer Res., August 15, 2006; 66(16): 8287 - 8292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. West, R. C. Ribeiro, J. Jenkins, C. Rodriguez-Galindo, B. C. Figueiredo, R. Kriwacki, and G. P. Zambetti Identification of a Novel Germ Line Variant Hotspot Mutant p53-R175L in Pediatric Adrenal Cortical Carcinoma. Cancer Res., May 15, 2006; 66(10): 5056 - 5062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Travis, C. S. Rabkin, L. M. Brown, J. M. Allan, B. P. Alter, C. B. Ambrosone, C. B. Begg, N. Caporaso, S. Chanock, A. DeMichele, et al. Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations J Natl Cancer Inst, January 4, 2006; 98(1): 15 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B C Figueiredo, R Sandrini, G P Zambetti, R M Pereira, C Cheng, W Liu, L Lacerda, M A Pianovski, E Michalkiewicz, J Jenkins, et al. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation J. Med. Genet., January 1, 2006; 43(1): 91 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nanda, L. P. Schumm, S. Cummings, J. D. Fackenthal, L. Sveen, F. Ademuyiwa, M. Cobleigh, L. Esserman, N. M. Lindor, S. L. Neuhausen, et al. Genetic Testing in an Ethnically Diverse Cohort of High-Risk Women: A Comparative Analysis of BRCA1 and BRCA2 Mutations in American Families of European and African Ancestry JAMA, October 19, 2005; 294(15): 1925 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Spunt, T. A. Sweeney, M. M. Hudson, C. A. Billups, M. J. Krasin, and A. L. Hester Late Effects of Pelvic Rhabdomyosarcoma and Its Treatment in Female Survivors J. Clin. Oncol., October 1, 2005; 23(28): 7143 - 7151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Bachinski, S.-E. Olufemi, X. Zhou, C.-C. Wu, L. Yip, S. Shete, G. Lozano, C. I. Amos, L. C. Strong, and R. Krahe Genetic Mapping of a Third Li-Fraumeni Syndrome Predisposition Locus to Human Chromosome 1q23 Cancer Res., January 15, 2005; 65(2): 427 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Garber and K. Offit Hereditary Cancer Predisposition Syndromes J. Clin. Oncol., January 10, 2005; 23(2): 276 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Izzotti, C. Cartiglia, M. Longobardi, M. Bagnasco, A. Merello, M. You, R. A. Lubet, and S. De Flora Gene Expression in the Lung of p53 Mutant Mice Exposed to Cigarette Smoke Cancer Res., December 1, 2004; 64(23): 8566 - 8572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Olivier, D. E. Goldgar, N. Sodha, H. Ohgaki, P. Kleihues, P. Hainaut, and R. A. Eeles Li-Fraumeni and Related Syndromes: Correlation between Tumor Type, Family Structure, and TP53 Genotype Cancer Res., October 15, 2003; 63(20): 6643 - 6650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vazquez, A. Castellote, J. Piqueras, P. Ortuno, J. Sanchez-Toledo, P. Nogues, and J. Lucaya Second Malignancies in Pediatric Patients: Imaging Findings and Differential Diagnosis RadioGraphics, September 1, 2003; 23(5): 1155 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A-M Martin, P A Kanetsky, B Amirimani, T A Colligon, G Athanasiadis, H A Shih, M R Gerrero, K Calzone, T R Rebbeck, and B L Weber Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1? J. Med. Genet., April 1, 2003; 40(4): e34 - 34. [Full Text] [PDF]
|
|
|
|
 |
|
 H P McDowell Update on childhood rhabdomyosarcoma Arch. Dis. Child., April 1, 2003; 88(4): 354 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Miyaki, T Iijima, M Ohue, Y Kita, T Hishima, T Kuroki, T Iwama, and T Mori A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours Gut, February 1, 2003; 52(2): 304 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D G R Evans, J M Birch, M Thorneycroft, G McGown, F Lalloo, and J M Varley Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome J. Med. Genet., December 1, 2002; 39(12): 941 - 944. [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. O'Neill, H. Blondal, P. Yang, G. H. Olafsdottir, H. Sigvaldason, R. B. Jenkins, D. W. Kimmel, B. W. Scheithauer, W. A. Rocca, J. Bjornsson, et al. Risk of Cancer among Relatives of Patients with Glioma Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 921 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J V M G Bovee, R J B Sakkers, M J A Geirnaerdt, A H M Taminiau, and P C W Hogendoorn Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses J. Clin. Pathol., March 1, 2002; 55(3): 226 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vahteristo, A. Tamminen, P. Karvinen, H. Eerola, C. Eklund, L. A. Aaltonen, C. Blomqvist, K. Aittomaki, and H. Nevanlinna p53, CHK2, and CHK1 Genes in Finnish Families with Li-Fraumeni Syndrome: Further Evidence of CHK2 in Inherited Cancer Predisposition Cancer Res., August 1, 2001; 61(15): 5718 - 5722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Ribeiro, F. Sandrini, B. Figueiredo, G. P. Zambetti, E. Michalkiewicz, A. R. Lafferty, L. DeLacerda, M. Rabin, C. Cadwell, G. Sampaio, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma PNAS, July 31, 2001; 98(16): 9330 - 9335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kimura, K. Shinmura, T. Hasegawa, Y. Beppu, R. Yokoyama, and J. Yokota Germline p53 Mutation in a Patient with Multiple Primary Cancers Jpn. J. Clin. Oncol., July 1, 2001; 31(7): 349 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Peshkin, T. A. DeMarco, B. M. Brogan, C. Lerman, and C. Isaacs BRCA1/2 Testing: Complex Themes in Result Interpretation J. Clin. Oncol., May 1, 2001; 19(9): 2555 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. BOUGEARD, J.-M. LIMACHER, C. MARTIN, F. CHARBONNIER, A. KILLIAN, O. DELATTRE, M. LONGY, P. JONVEAUX, J.-P. FRICKER, D. STOPPA-LYONNET, et al. Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome J. Med. Genet., April 1, 2001; 38(4): 253 - 257. [Full Text]
|
|
|
|
|
|
K. E. Nichols, D. Malkin, J. E. Garber, J. F. Fraumeni Jr., and F. P. Li Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 83 - 87. [Abstract] [Full Text]
|
|
|
|
|
|
B.-S. Herbert, A. C. Wright, C. M. Passons, W. E. Wright, I. U. Ali, L. Kopelovich, and J. W. Shay Effects of Chemopreventive and Antitelomerase Agents on the Spontaneous Immortalization of Breast Epithelial Cells J Natl Cancer Inst, January 3, 2001; 93(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. CHOMPRET, A. ABEL, D. STOPPA-LYONNET, L. BRUGIÈRES, S. PAGÈS, J. FEUNTEUN, and C. BONAÏTI-PELLIÉ Sensitivity and predictive value of criteria for p53 germline mutation screening J. Med. Genet., January 1, 2001; 38(1): 43 - 47. [Full Text]
|
|
|
|
|
|
J. Alsner, M. Yilmaz, P. Guldberg, L. L. Hansen, and J. Overgaard Heterogeneity in the Clinical Phenotype of TP53 Mutations in Breast Cancer Patients Clin. Cancer Res., October 1, 2000; 6(10): 3923 - 3931. [Abstract] [Full Text]
|
|
|
|
|
|
C. PORTWINE, J. LEES, S. VERSELIS, F. P LI, and D. MALKIN Absence of germline p16INK4a alterations in p53 wild type Li-Fraumeni syndrome families J. Med. Genet., August 1, 2000; 37(8): 13e - 13. [Full Text]
|
|
|
|
 |
|
 K. M. D. La Perle, S. M. Jhiang, and C. C. Capen Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas Am. J. Pathol., August 1, 2000; 157(2): 671 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Dickson, W. C. Hahn, Y. Ino, V. Ronfard, J. Y. Wu, R. A. Weinberg, D. N. Louis, F. P. Li, and J. G. Rheinwald Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics Mol. Cell. Biol., February 15, 2000; 20(4): 1436 - 1447. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. W. Bell, J. M. Varley, T. E. Szydlo, D. H. Kang, D. C. Wahrer, K. E. Shannon, M. Lubratovich, S. J. Verselis, K. J. Isselbacher, J. F. Fraumeni, et al. Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome Science, December 24, 1999; 286(5449): 2528 - 2531. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. J. Vanasse, P. Concannon, and D. M. Willerford Regulated Genomic Instability and Neoplasia in the Lymphoid Lineage Blood, December 15, 1999; 94(12): 3997 - 4010. [Full Text] [PDF]
|
|
|
|
|
|
N. J van Orsouw, R. K Dhanda, Y. Elhaji, S. A Narod, F. P Li, C. Eng, and J. Vijg A highly accurate, low cost test for BRCA1 mutations J. Med. Genet., October 1, 1999; 36(10): 747 - 753. [Abstract] [Full Text]
|
|
|
|
|
|
M.-D. Tabone, P. Terrier, H. Pacquement, M. Brunat-Mentigny, C. Schmitt, A. Babin-Boilletot, H. H. Mahmoud, and C. Kalifa Outcome of Radiation-Related Osteosarcoma After Treatment of Childhood and Adolescent Cancer: A Study of 23 Cases J. Clin. Oncol., September 1, 1999; 17(9): 2789 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shinmura, T. Kohno, M. Takahashi, A. Sasaki, A. Ochiai, P. Guilford, A. Hunter, A. E. Reeve, H. Sugimura, N. Yamaguchi, et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations Carcinogenesis, June 1, 1999; 20(6): 1127 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Li Cancer Control in Susceptible Groups: Opportunities and Challenges J. Clin. Oncol., January 1, 1999; 17(2): 719 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Freedman Regulation of the p53 Protein by the MDM2 Oncoprotein--Thirty-eighth G. H. A. Clowes Memorial Award Lecture Cancer Res., January 1, 1999; 59(1): 1 - 7. [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Couch, M. L. DeShano, M. A. Blackwood, K. Calzone, J. Stopfer, L. Campeau, A. Ganguly, T. Rebbeck, B. L. Weber, L. Jablon, et al. BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer N. Engl. J. Med., May 15, 1997; 336(20): 1409 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Robbins p53 and Breast Cancer International Journal of Surgical Pathology, October 1, 1996; 4(2): 93 - 110. [Abstract] [PDF]
|
|
|
|
|
|
C. B. Pratt Pediatric Clinical Trials Oncologist, June 1, 1996; 1(3): 169 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Olsen, J. D. Boice, N. Seersholm, A. Bautz, and J. F. Fraumeni Cancer in the Parents of Children with Cancer N. Engl. J. Med., December 14, 1995; 333(24): 1594 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Goldstein, M. C. Fraser, J. P. Struewing, C. J. Hussussian, K. Ranade, D. P. Zametkin, L. S. Fontaine, S. M. Organic, N. C. Dracopoli, W. H. Clark, et al. Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4 Mutations N. Engl. J. Med., October 12, 1995; 333(15): 970 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M Hawkins Pregnancy outcome and offspring after childhood cancer BMJ, October 22, 1994; 309(6961): 1034 - 1034. [Full Text]
|
|
|
|
|
|
D G R Evans, I S Fentiman, K McPherson, D Asbury, B A J Ponder, and A Howell Fortnightly Review: Familial breast cancer BMJ, January 15, 1994; 308(6922): 183 - 187. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. H. Tomlinson, B. W. Scheithauer, and R. B. Jenkins Topical Review Article: Medulloblastoma: II. A Pathobiologic Overview J Child Neurol, July 1, 1992; 7(3): 240 - 252. [Abstract] [PDF]
|
|
|
|
|
|
D Malkin, F. Li, L. Strong, J. Fraumeni Jr, C. Nelson, D. Kim, J Kassel, M. Gryka, F. Bischoff, M. Tainsky, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science, November 30, 1990; 250(4985): 1233 - 1238. [Abstract] [PDF]
|
|
|
|
|
|
T. J. Jonasdottir, C. S. Mellersh, L. Moe, R. Heggebo, H. Gamlem, E. A. Ostrander, and F. Lingaas Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs PNAS, April 11, 2000; 97(8): 4132 - 4137. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
